What Analysts Are Saying About Chemours Stock
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Chemours (NYSE:CC) over the past three months, with a recent average 12-month price target of $29.25. Key analysts have adjusted their ratings and price targets, reflecting evolving market conditions and company performance.
June 07, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts have provided mixed ratings for Chemours (NYSE:CC) over the past three months, with a recent average 12-month price target of $29.25. Key analysts have adjusted their ratings and price targets, reflecting evolving market conditions and company performance.
The mixed ratings and adjustments in price targets by key analysts indicate uncertainty in the short-term performance of Chemours. The average price target has increased, but the varied ratings suggest a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100